| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Mirella Meregalli | Q53243014 |
| Yvan Torrente | Q56670654 | ||
| P2093 | author name string | Andrea Farini | |
| Clementina Sitzia | |||
| Daniele Parolini | |||
| Letizia Cassinelli | |||
| Marzia Belicchi | |||
| Paola Razini | |||
| P2860 | cites work | Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis | Q24313411 |
| Myogenic specification of side population cells in skeletal muscle | Q24672806 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues | Q28208566 | ||
| Cellular and molecular regulation of muscle regeneration | Q28238078 | ||
| Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs | Q28274324 | ||
| Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping | Q28291830 | ||
| Direct isolation of human central nervous system stem cells | Q28318408 | ||
| Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts | Q29302095 | ||
| Marrow stromal cells as stem cells for nonhematopoietic tissues | Q29618770 | ||
| Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
| Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood | Q30163911 | ||
| Mesenchymal progenitor cells in human umbilical cord blood | Q30168979 | ||
| Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation | Q33185127 | ||
| Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner | Q33438830 | ||
| The muscular dystrophies | Q33792223 | ||
| Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice | Q33811436 | ||
| The molecular regulation of myogenesis | Q33873253 | ||
| Long-term self-renewal of postnatal muscle-derived stem cells | Q33877074 | ||
| Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. | Q40818700 | ||
| The fate of individual myoblasts after transplantation into muscles of DMD patients | Q40883106 | ||
| Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells | Q42448117 | ||
| Importance of the SDF-1:CXCR4 axis in myocardial repair | Q42570987 | ||
| Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. | Q42819955 | ||
| Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice | Q43769886 | ||
| Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis | Q43831215 | ||
| Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans | Q43992517 | ||
| Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice | Q45858191 | ||
| Muscle regeneration by bone marrow-derived myogenic progenitors | Q45885806 | ||
| Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. | Q45888978 | ||
| Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns | Q45889492 | ||
| Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain | Q46566592 | ||
| Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles | Q46828411 | ||
| Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells | Q47864474 | ||
| Vascular pericytes express osteogenic potential in vitro and in vivo | Q48017613 | ||
| Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant | Q48093756 | ||
| CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. | Q48383517 | ||
| Clonal multipotency of skeletal muscle-derived stem cells between mesodermal and ectodermal lineage | Q50675672 | ||
| Direct isolation of satellite cells for skeletal muscle regeneration. | Q50756094 | ||
| Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. | Q50797491 | ||
| Regeneration and transdifferentiation potential of muscle-derived stem cells propagated as myospheres. | Q51237436 | ||
| Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. | Q53252919 | ||
| Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. | Q54493066 | ||
| Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. | Q54602083 | ||
| Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. | Q54789059 | ||
| Induced dystrophin exon skipping in human muscle explants | Q33998680 | ||
| Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers | Q34025219 | ||
| Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. | Q34180122 | ||
| Myoblasts in pattern formation and gene therapy | Q34354982 | ||
| Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells | Q34479398 | ||
| Expression of full-length utrophin prevents muscular dystrophy in mdx mice | Q34482808 | ||
| Muscle-derived stem cells: characterization and potential for cell-mediated therapy | Q34488738 | ||
| Self-renewal and expansion of single transplanted muscle stem cells | Q34833140 | ||
| Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. | Q35124906 | ||
| Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs | Q35475301 | ||
| Cord blood in regenerative medicine: do we need immune suppression? | Q35633105 | ||
| Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle | Q35835194 | ||
| Mesenchymal stem cells: isolation and therapeutics | Q35877577 | ||
| Mesenchymal stem cells: progress toward promise | Q36205474 | ||
| Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration | Q36324366 | ||
| Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. | Q36325014 | ||
| Muscle stem cells in development, regeneration, and disease | Q36526535 | ||
| Stem cell based therapies to treat muscular dystrophy | Q36621005 | ||
| Advances in the treatment of Parkinson's disease | Q36720216 | ||
| Stem and progenitor cells in skeletal muscle development, maintenance, and therapy | Q36771273 | ||
| Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles | Q36879972 | ||
| Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides | Q36991846 | ||
| New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. | Q36993575 | ||
| Skeletal muscle stem cell birth and properties | Q37006306 | ||
| Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue | Q37132476 | ||
| Heterogeneity of embryonic and adult stem cells | Q37317339 | ||
| Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes | Q37492370 | ||
| Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. | Q37633743 | ||
| Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells | Q38340941 | ||
| Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis | Q39501938 | ||
| In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study | Q39502175 | ||
| Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. | Q39716553 | ||
| Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability | Q39737560 | ||
| Mobilization of endothelial progenitor cells into the circulation in burned patients | Q40183091 | ||
| Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells | Q40243228 | ||
| TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts | Q40486854 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Duchenne muscular dystrophy | Q1648484 |
| RUN and FYVE domain containing 3 | Q21990069 | ||
| P304 | page(s) | 4251-62 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | FEBS Journal | Q1388041 |
| P1476 | title | Perspectives of stem cell therapy in Duchenne muscular dystrophy | |
| P478 | volume | 280 |
| Q100533732 | Dystrophin Dp71ab is monoclonally expressed in human satellite cells and enhances proliferation of myoblast cells |
| Q28087402 | Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease |
| Q47147004 | Insulin-Like Growth Factor Binding Protein-6 Alters Skeletal Muscle Differentiation of Human Mesenchymal Stem Cells |
| Q35121191 | Internalization and fate of silica nanoparticles in C2C12 skeletal muscle cells: evidence of a beneficial effect on myoblast fusion |
| Q34152280 | Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials |
| Q34322871 | Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications |
| Q38577279 | Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy |
| Q50280511 | Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling |
| Q58719281 | The Importance of Biophysical and Biochemical Stimuli in Dynamic Skeletal Muscle Models |
| Q26800207 | The quasi-parallel lives of satellite cells and atrophying muscle |
| Q50460163 | Therapeutic effects of mouse adipose-derived stem cells and losartan in the skeletal muscle of injured mdx mice |
| Q39699112 | Understanding the process of fibrosis in Duchenne muscular dystrophy. |
Search more.